The Sideways Answer: Why the Safest Clinical AI Does Not Have to Think for Itself

Edward de Bono coined the term lateral thinking in 1967 to describe a specific kind of problem solving: instead of digging deeper into the same hole, you dig a different hole entirely. You do not work harder on the conventional approach. You step sideways and question whether the conventional approach is addressing the right version of the problem in the first place. That distinction is the most important frame in healthcare AI governance right now, and almost nobody in the industry is using it.

The conventional approach to clinical AI safety is directional and consistent: build autonomous AI agents, then build governance infrastructure around them to catch what they get wrong. Better audit trails. Stronger override protection. Documented dissent channels. More structured accountability layers between the AI output and the clinical action. All of it is correct. All of it is necessary in environments where autonomous AI is already deployed. And all of it is digging deeper into the same hole.

The lateral thinking answer starts from a different question entirely. Not: how do we govern autonomous AI more effectively? But: at which decision points in the clinical workflow should AI never be autonomous in the first place?

That question changes everything about how governance is approached, how AI architecture is designed, and how independent practices should be thinking about every AI adoption decision they make right now.

The Industry Is Solving a Real Problem the Hard Way

The governance conversation that has dominated healthcare AI in 2025 and 2026 is legitimate and important. MedCity News, writing on scaling autonomous AI in healthcare, described the core engineering challenge with precision: high-level governance policies must translate into deterministic engineering controls that regulate AI in clinical environments. Governance frameworks are only effective when they can be enforced consistently at the point of care.

That framing is correct. The problem is that it assumes autonomous AI is the starting point and deterministic controls are the layer you add after deployment to enforce the governance framework around it. The autonomous agent is built first. The guardrails come second.

This sequence produces the retrofit problem. Every AI tool deployed without governance infrastructure in place becomes a tool that must be governed retroactively, after the architecture is already set, after the clinical workflows are already built around it, and after the practice has already developed operational dependencies on its autonomous behavior. The governance layer is always playing catch-up to an AI stack that was never designed with governance as an architectural constraint.

Those numbers are the retrofit problem made visible. Adoption ran ahead of architecture. Governance is now trying to catch a stack it was never included in designing. The conventional answer, more governance infrastructure, is the right response to that reality. It is also evidence that the conventional sequence, autonomous AI first and governance second, produces a persistent and expensive lag that never fully closes.

What If the Autonomy Was Never There in the First Place?

De Bono described vertical thinking as selective and judgmental, focused on correctness within given parameters. Lateral thinking is generative and provocative, prioritizing what he called the movement value: the ability to shift position entirely rather than refine within the current one.

The movement in healthcare AI governance is this: instead of asking how to govern autonomous AI at a given decision point, ask whether that decision point should be autonomous at all.

This is not an argument against AI. It is an argument for architectural precision about where in the clinical workflow autonomous action is appropriate and where it is not. MedCity News articulated the distinction clearly in its March 2026 analysis of clinical AI deployment: human-in-the-loop applies to high-risk or irreversible decisions such as clinical diagnoses, medication changes, or high-value claims decisions where clinician approval is required. Human-on-the-loop is appropriate for low-risk, reversible administrative tasks like scheduling, transcription, and documentation routing.

That distinction, human-in-the-loop versus human-on-the-loop, is the beginning of the lateral thinking architecture. It is not a governance policy layered over an autonomous system. It is an architectural decision made before the system is built, defining which decision points require structural human authorization and which ones can proceed autonomously with retrospective monitoring.

Conventional Versus Lateral: The Architectural Difference

The difference between the conventional and lateral approaches is not philosophical. It is operational. Here is what it looks like at the decision-point level in a clinical workflow.

The right column is not a description of less capable AI. It is a description of AI deployed with architectural precision about where human judgment is a structural requirement and where it is not. The AI in every right-column scenario does exactly what autonomous AI should do: it handles the high-volume, low-risk decisions efficiently, at scale, without burdening clinical staff. And at the decision points where autonomous action creates unacceptable clinical or compliance risk, it does not proceed. Not because a governance layer caught it. Because the architecture does not allow it.

This Is Not Theory. It Is a Working Architecture.

The lateral thinking argument described in this article is not a position developed in response to a governance problem. It is the architectural principle behind the AI platform built at MaxonaCare, a home care agency operating an autonomous AI platform called Aveleo AI.

The platform handles complex home care workflows autonomously across scheduling, care coordination, and operational functions. It does not ask for human authorization at every step. That would eliminate the efficiency advantage that makes AI adoption worthwhile. But at the decision points where autonomous action creates unacceptable clinical or compliance risk, the architecture does not make those decisions. The workflow cannot proceed past those points without documented human authorization. Not because a governance layer monitors the output and flags anomalies. Because the system was never designed to be autonomous there.

The result is a system that operates with the efficiency of autonomous AI and the accountability of a governance-first architecture, because those two goals were never treated as competing. They were designed together from the beginning.

What This Means for a Practice That Did Not Build Its Own AI Platform

Most independent practices did not build their AI stack. They adopted vendor tools, signed BAAs, and began using the tools according to vendor instructions. The autonomous behavior of those tools was determined by the vendor's architecture, not by any deliberate decision the practice made about where autonomy was appropriate.

That is the starting point for most independent practices in 2026. The lateral thinking architecture cannot be retrofitted perfectly onto a vendor tool whose autonomous behavior is fixed. But it can be applied at the deployment and configuration level in ways that matter significantly for both clinical safety and compliance exposure.

The questions every independent practice should be asking about every AI tool currently operating in its clinical workflow are the same questions the lateral thinking architecture starts with:

These four questions will not turn a vendor tool into a purpose-built deterministic architecture. But they will produce the documented governance posture that OCR, payers, and accreditation bodies are increasingly expecting to see. And they will surface, for the first time for most independent practices, a clear-eyed picture of where autonomous AI is operating in their clinical workflows without any defined boundary.

Veriphy: Where the Lateral Thinking Architecture Meets Independent Practice Reality

The Agent Workflow Registry in Veriphy's Enterprise tier is the tool that translates the lateral thinking architecture into operational reality for independent practices that did not build their own AI platform.

It does not change the underlying behavior of the AI tools your practice has already deployed. What it does is create, for the first time, a documented record of the scope of authority you have defined for each of those tools. What decisions the agent is authorized to make autonomously. What decisions require a human review gate before the agent proceeds. What the escalation pathway is when the agent encounters a situation outside its defined parameters.

That documentation is the beginning of the lateral thinking governance architecture for an independent practice. It forces the four questions above to be answered explicitly, in writing, in a timestamped compliance record. And it produces the audit-ready evidence that your practice has made deliberate architectural decisions about where its AI agents operate autonomously and where they do not.

The practices that answer those questions now, before the regulatory and payer environment requires it, will have years of documented governance posture when the questions become mandatory. The ones that answer them under pressure will be building the architecture retroactively, which is exactly the retrofit problem the lateral thinking approach was designed to avoid.

This article is the flagship piece in Elevare's AI Governance Series. Related reading: When No One Can Say Stop, Agentic AI Is Coming to Your Clinic. Who's Governing It?, and The Clinics That Govern AI Well Will Outperform Those That Don't.